Search

Your search keyword '"Rodriguez, M Alma"' showing total 207 results

Search Constraints

Start Over You searched for: Author "Rodriguez, M Alma" Remove constraint Author: "Rodriguez, M Alma"
207 results on '"Rodriguez, M Alma"'

Search Results

1. NCCN Guidelines® Insights: Survivorship, Version 1.2023.

2. NCCN Guidelines® Insights: Survivorship, Version 1.2022.

3. Survivorship, Version 1.2021.

5. Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET–CT-documented First Remission

9. Introduction

11. Mantle cell lymphomas

13. The survival outcome of patients with relapsed/refractory peripheral T‐cell lymphoma‐not otherwise specified and angioimmunoblastic T‐cell lymphoma

17. Survivorship, Version 2.2020: Featured Updates to the NCCN Guidelines

21. Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

22. NCCN Guidelines Insights: Survivorship, Version 2.2020

23. Survivorship, Version 2.2019: Featured Updates to the NCCN Guidelines

26. Dose-related safety and immunogenicity of baculovirus-expressed trivalent influenza vaccine: a double-blind, controlled trial in adult patients with non-Hodgkin B cell lymphoma

27. Psychological adjustment and sleep quality in a randomized trial of the effects of a Tibetan yoga intervention in patients with lymphoma

28. CD20 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin’s Disease: Associations With Presenting Features and Clinical Outcome

32. NCCN Guidelines Insights: Survivorship, Version 2.2019

33. Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma

35. Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

36. Predictors of Hypothyroidism in Hodgkin Lymphoma Survivors After Intensity Modulated Versus 3-Dimensional Radiation Therapy

37. Phase 2 trial of bortezomib in combination with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with bortezomib, rituximab, methotrexate, and cytarabine for untreated mantle cell lymphoma

38. The risk of central nervous system relapses in patients with peripheral T-cell lymphoma

40. Survivorship, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

41. Survivorship: Healthy Lifestyles, Version 2.2014: Clinical Practice Guidelines in Oncology

42. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma

43. Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma

44. Management strategies and outcomes for very elderly patients with diffuse large B-cell lymphoma

45. NCCN Guidelines Insights: Survivorship, Version 1.2016

46. Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease

47. Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma

48. Targeting Wnt pathway in mantle cell lymphoma-initiating cells

49. Single-Institution Experience in the Treatment of Primary Mediastinal B Cell Lymphoma Treated With Immunochemotherapy in the Setting of Response Assessment by 18Fluorodeoxyglucose Positron Emission Tomography

50. Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma

Catalog

Books, media, physical & digital resources